Hormonal regulation of lipolysis and phosphorylase activity in human fat cells.
Prostaglandin E(1) (PGE(1)) at a concentration of 1 ng/ml antagonized theophylline, and norepinephrine induced release of glycerol and free fatty acids (FFA) in human fat cell preparations. Insulin at higher doses also inhibited theophylline-stimulated lipolysis. The N(6)-2-0'dibutyryl derivative of cyclic adenosine monophosphate (DCAMP) stimulated lipolysis. Prostaglandin E(1) did not significantly inhibit the lipid mobilizing effects of DCAMP. Changes in glycogen phosphorylase activity after treatment with theophylline, norepinephrine, DCAMP, and PGE(1) paralleled those of lipolysis. These results suggest that in man as in experimental animals lipolysis and phosphorylase activity are regulated through processes involving cyclic AMP and that PGE(1) appears to exert its antilipolytic effect in human fat cells, as in rat fat cells, by interfering at the level of adenyl cyclase with the accumulation of cyclic AMP.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005964:Glucosyltransferases / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D050356:Lipid Metabolism; D009638:Norepinephrine; D011453:Prostaglandins / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D013806:Theophylline / Q000037:antagonists & inhibitors
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011453:Prostaglandins; D013806:Theophylline; D000242:Cyclic AMP; D005964:Glucosyltransferases; D000262:Adenylyl Cyclases; D005990:Glycerol; D009638:Norepinephrine